119 related articles for article (PubMed ID: 21918187)
1. Characterization of a transitional preplasmablast population in the process of human B cell to plasma cell differentiation.
Jourdan M; Caraux A; Caron G; Robert N; Fiol G; Rème T; Bolloré K; Vendrell JP; Le Gallou S; Mourcin F; De Vos J; Kassambara A; Duperray C; Hose D; Fest T; Tarte K; Klein B
J Immunol; 2011 Oct; 187(8):3931-41. PubMed ID: 21918187
[TBL] [Abstract][Full Text] [Related]
2. Microarray-based understanding of normal and malignant plasma cells.
De Vos J; Hose D; Rème T; Tarte K; Moreaux J; Mahtouk K; Jourdan M; Goldschmidt H; Rossi JF; Cremer FW; Klein B
Immunol Rev; 2006 Apr; 210():86-104. PubMed ID: 16623766
[TBL] [Abstract][Full Text] [Related]
3. A CRISPR/Cas9-mediated screen identifies determinants of early plasma cell differentiation.
Xiong E; Popp O; Salomon C; Mertins P; Kocks C; Rajewsky K; Chu VT
Front Immunol; 2022; 13():1083119. PubMed ID: 36685499
[TBL] [Abstract][Full Text] [Related]
4. GenomicScape: an easy-to-use web tool for gene expression data analysis. Application to investigate the molecular events in the differentiation of B cells into plasma cells.
Kassambara A; Rème T; Jourdan M; Fest T; Hose D; Tarte K; Klein B
PLoS Comput Biol; 2015 Jan; 11(1):e1004077. PubMed ID: 25633866
[TBL] [Abstract][Full Text] [Related]
5. Naive and memory human B cells have distinct requirements for STAT3 activation to differentiate into antibody-secreting plasma cells.
Deenick EK; Avery DT; Chan A; Berglund LJ; Ives ML; Moens L; Stoddard JL; Bustamante J; Boisson-Dupuis S; Tsumura M; Kobayashi M; Arkwright PD; Averbuch D; Engelhard D; Roesler J; Peake J; Wong M; Adelstein S; Choo S; Smart JM; French MA; Fulcher DA; Cook MC; Picard C; Durandy A; Klein C; Holland SM; Uzel G; Casanova JL; Ma CS; Tangye SG
J Exp Med; 2013 Nov; 210(12):2739-53. PubMed ID: 24218138
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor ABF-1 suppresses plasma cell differentiation but facilitates memory B cell formation.
Chiu YK; Lin IY; Su ST; Wang KH; Yang SY; Tsai DY; Hsieh YT; Lin KI
J Immunol; 2014 Sep; 193(5):2207-17. PubMed ID: 25070843
[TBL] [Abstract][Full Text] [Related]
7. B-type suppression: a role played by "regulatory B cells" or "regulatory plasma cells"?
Ries S; Hilgenberg E; Lampropoulou V; Shen P; Dang VD; Wilantri S; Sakwa I; Fillatreau S
Eur J Immunol; 2014 May; 44(5):1251-7. PubMed ID: 24615065
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-Mediated Regulation of Plasma Cell Generation: IL-21 Takes Center Stage.
Moens L; Tangye SG
Front Immunol; 2014; 5():65. PubMed ID: 24600453
[TBL] [Abstract][Full Text] [Related]
9. New Insights in the Immunobiology of IL-1 Family Members.
van de Veerdonk FL; Netea MG
Front Immunol; 2013; 4():167. PubMed ID: 23847614
[TBL] [Abstract][Full Text] [Related]
10. The establishment of the plasma cell survival niche in the bone marrow.
Chu VT; Berek C
Immunol Rev; 2013 Jan; 251(1):177-88. PubMed ID: 23278749
[TBL] [Abstract][Full Text] [Related]
11. ZBTB32 is an early repressor of the CIITA and MHC class II gene expression during B cell differentiation to plasma cells.
Yoon HS; Scharer CD; Majumder P; Davis CW; Butler R; Zinzow-Kramer W; Skountzou I; Koutsonanos DG; Ahmed R; Boss JM
J Immunol; 2012 Sep; 189(5):2393-403. PubMed ID: 22851713
[TBL] [Abstract][Full Text] [Related]
12. CD19-CD45 low/- CD38 high/CD138+ plasma cells enrich for human tumorigenic myeloma cells.
Kim D; Park CY; Medeiros BC; Weissman IL
Leukemia; 2012 Dec; 26(12):2530-7. PubMed ID: 22733078
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells.
Shi W; Liao Y; Willis SN; Taubenheim N; Inouye M; Tarlinton DM; Smyth GK; Hodgkin PD; Nutt SL; Corcoran LM
Nat Immunol; 2015 Jun; 16(6):663-73. PubMed ID: 25894659
[TBL] [Abstract][Full Text] [Related]
14. EZH2 is overexpressed in transitional preplasmablasts and is involved in human plasma cell differentiation.
Herviou L; Jourdan M; Martinez AM; Cavalli G; Moreaux J
Leukemia; 2019 Aug; 33(8):2047-2060. PubMed ID: 30755708
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow stromal cell antigen 2: Tumor biology, signaling pathway and therapeutic targeting (Review).
Yu H; Bian Q; Wang X; Wang X; Lai L; Wu Z; Zhao Z; Ban B
Oncol Rep; 2024 Mar; 51(3):. PubMed ID: 38240088
[TBL] [Abstract][Full Text] [Related]
16. Aberrant B-cell activation and B-cell subpopulations in rheumatoid arthritis: analysis by clinical activity, autoantibody seropositivity, and treatment.
Morales-Núñez JJ; Muñoz-Valle JF; García-Chagollán M; Cerpa-Cruz S; Martínez-Bonilla GE; Medina-Rosales VM; Díaz-Pérez SA; Nicoletti F; Hernández-Bello J
Clin Exp Immunol; 2023 Dec; 214(3):314-327. PubMed ID: 37464892
[TBL] [Abstract][Full Text] [Related]
17. SEC-seq: association of molecular signatures with antibody secretion in thousands of single human plasma cells.
Cheng RY; de Rutte J; Ito CEK; Ott AR; Bosler L; Kuo WY; Liang J; Hall BE; Rawlings DJ; Di Carlo D; James RG
Nat Commun; 2023 Jun; 14(1):3567. PubMed ID: 37322036
[TBL] [Abstract][Full Text] [Related]
18. NMP4, an Arbiter of Bone Cell Secretory Capacity and Regulator of Skeletal Response to PTH Therapy.
Korff C; Atkinson E; Adaway M; Klunk A; Wek RC; Vashishth D; Wallace JM; Anderson-Baucum EK; Evans-Molina C; Robling AG; Bidwell JP
Calcif Tissue Int; 2023 Jul; 113(1):110-125. PubMed ID: 37147466
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of antibody-secreting cells infiltrating autoimmune tissues.
Giovannini D; Belbezier A; Baillet A; Bouillet L; Kawano M; Dumestre-Perard C; Clavarino G; Noble J; Pers JO; Sturm N; Huard B
Front Immunol; 2023; 14():1111366. PubMed ID: 36895558
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
